EQUITY RESEARCH MEMO

Genex Pharma

Generated 5/25/2026

Executive Summary

Conviction (model self-assessment)40/100

Genex Pharma is a private Indian pharmaceutical manufacturer established in 2020, specializing in a broad portfolio of generic and specialty medicines across cardiovascular, oncology, hormonal-infertility, anti-bacterials, and nutraceuticals. The company operates WHO-GMP-compliant formulation and API facilities in Baddi (Himachal Pradesh) and Tumkur (Karnataka), leveraging advanced aseptic and lyophilization technologies. With a focus on both domestic and export markets, Genex Pharma aims to address critical therapeutic needs through cost-effective, high-quality generics. Despite being a relatively new entrant, the company has built a substantial employee base of 200–500 and has established a presence in key therapeutic segments.

Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)